Lundbeck boosts Parkinson’s pipeline with acquisition

19-03-2018

Lundbeck boosts Parkinson’s pipeline with acquisition

designer491 / iStockphoto.com

Danish pharmaceutical company Lundbeck has boosted its pipeline of treatments for patients with Parkinson’s disease with the planned acquisition of Prexton Therapeutics.


Lundbeck, mergers & acquisitions, Parkinson’s disease, Prexton Therapeutics, Merck KGaA, pipeline, biopharma

LSIPR